The authors — Zahir Kanjee, MD; Ateev Mehrotra, MD; and Bruce Landon, MD — discussed how different types of care significantly affect a hospital’s margin. For example, the procedures that have been canceled during COVID-19, like hip and knee replacements, radiology tests and colonoscopies, are “cash cows” for hospitals. What has stayed are the services hospitals usually break even or lose money on, like prolonged stays in the ICU and emergency room services.
In “normal” times these services effectively balance each other out, with the profitable procedures subsidizing the unprofitable services, according to the physicians. But during a pandemic, hospitals have turned “almost exclusively to unprofitable treatment,” the physicians wrote. “It is no surprise that hospitals are running massive financial deficits. In every respect, the pandemic has exposed the discrepancy in how hospitals are paid for doing procedures compared to providing non-procedural medical care.”
The physicians offered three potential solutions for the reimbursement problem:
1. Fix imbalances in Medicare’s reimbursement rates
2. Put better mechanisms in place to update relative prices
3. Build up efforts to test new payment models
Read the full opinion piece here.
More articles on healthcare finance:
10 physician specialties that generate the most revenue for hospitals
20 large hospital networks received $5B in federal bailout funds
State-by-state breakdown of adjusted hospital expenses per inpatient day
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
